Multiple roles of MYC in integrating regulatory networks of pluripotent stem cells

Frontiers in Cell and Developmental Biology

Volumn 5, Issue , 2017, Pages

  Fagnocchi, Luca ^a,b   Zippo, Alessio ^a,b  

^a Istituto Nazionale di Genetica Molecolare   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Cancer; Epigenetic memory; Epigenetics; MYC; Pluripotent stem cells; Signaling pathways; Transcription regulatory networks

Indexed keywords

EID: 85040719644     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2017.00007     Document Type: Review

References (240)

1. Amente, S., Lania, L., and Majello, B. (2013). The histone LSD1 demethylase in stemness and cancer transcription programs. Biochim. Biophys. Acta 1829, 981-986. doi: 10.1016/j.bbagrm.2013.05.002
2. Araki, R., Hoki, Y., Uda, M., Nakamura, M., Jincho, Y., Tamura, C., et al. (2011). Crucial role of c-Myc in the generation of induced pluripotent stem cells. Stem Cells 29, 1362-1370. doi: 10.1002/stem.685
3. Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian, N., and Lovell-Badge, R. (2003). Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126-140. doi: 10.1101/gad.224503
4. Avior, Y., Sagi, I., and Benvenisty, N. (2016). Pluripotent stem cells in disease modelling and drug discovery. Nat. Rev. Mol. Cell Biol. 17, 170-182. doi: 10.1038/nrm.2015.27
5. Barrett, J., Birrer, M. J., Kato, G. J., Dosaka-Akita, H., and Dang, C. V. (1992). Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol. Cell. Biol. 12, 3130-3137. doi: 10.1128/MCB.12.7.3130
6. Barroso-Deljesus, A., Romero-Lopez, C., Lucena-Aguilar, G., Melen, G. J., Sanchez, L., Ligero, G., et al. (2008). Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol. Cell. Biol. 28, 6609-6619. doi: 10.1128/MCB.00398-08
7. Baudino, T. A., Mckay, C., Pendeville-Samain, H., Nilsson, J. A., Maclean, K. H., White, E. L., et al. (2002). c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 16, 2530-2543. doi: 10.1101/gad.1024602
8. Bellin, M., Marchetto, M. C., Gage, F. H., and Mummery, C. L. (2012). Induced pluripotent stem cells: the new patient? Nat. Rev. Mol. Cell Biol. 13, 713-726. doi: 10.1038/nrm3448
9. Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., et al. (2006). A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326. doi: 10.1016/j.cell.2006.02.041
10. Blackwell, T. K., Huang, J., Ma, A., Kretzner, L., Alt, F. W., Eisenman, R. N., et al. (1993). Binding of myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13, 5216-5224. doi: 10.1128/MCB.13.9.5216
11. Blackwell, T. K., Kretzner, L., Blackwood, E. M., Eisenman, R. N., and Weintraub, H. (1990). Sequence-specific DNA binding by the c-Myc protein. Science 250, 1149-1151. doi: 10.1126/science.2251503
12. Blackwood, E. M., and Eisenman, R. N. (1991). Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251, 1211-1217. doi: 10.1126/science.2006410
13. Bonasio, R., Tu, S., and Reinberg, D. (2010). Molecular signals of epigenetic states. Science 330, 612-616. doi: 10.1126/science.1191078
14. Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956. doi: 10.1016/j.cell.2005.08.020
15. Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., et al. (2006). Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349-353. doi: 10.1038/nature04733
16. Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H., and Helin, K. (2006). Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 20, 1123-1136. doi: 10.1101/gad.381706
17. Brenner, C., Deplus, R., Didelot, C., Loriot, A., Vire, E., De Smet, C., et al. (2005). Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24, 336-346. doi: 10.1038/sj.emboj.7600509
18. Bretones, G., Delgado, M. D., and Leon, J. (2015). Myc and cell cycle control. Biochim. Biophys. Acta 1849, 506-516. doi: 10.1016/j.bbagrm.2014.03.013
19. Brons, I. G., Smithers, L. E., Trotter, M. W., Rugg-Gunn, P., Sun, B., Chuva De Sousa Lopes, S. M., et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195. doi: 10.1038/nature05950
20. Buganim, Y., Faddah, D. A., and Jaenisch, R. (2013). Mechanisms and models of somatic cell reprogramming. Nat. Rev. Genet. 14, 427-439. doi: 10.1038/nrg3473
21. Cairo, S., Wang, Y., De Reynies, A., Duroure, K., Dahan, J., Redon, M. J., et al. (2010). Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc. Natl. Acad. Sci. U.S.A. 107, 20471-20476. doi: 10.1073/pnas.1009009107
22. Cao, Y., Guo, W. T., Tian, S., He, X., Wang, X. W., Liu, X., et al. (2015). miR-290/371-Mbd2-Myc circuit regulates glycolytic metabolism to promote pluripotency. EMBO J. 34, 609-623. doi: 10.15252/embj.201490441
23. Carbognin, E., Betto, R. M., Soriano, M. E., Smith, A. G., and Martello, G. (2016). Stat3 promotes mitochondrial transcription and oxidative respiration during maintenance and induction of naive pluripotency. EMBO J. 35, 618-634. doi: 10.15252/embj.201592629
24. Card, D. A., Hebbar, P. B., Li, L., Trotter, K. W., Komatsu, Y., Mishina, Y., et al. (2008). Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol. Cell. Biol. 28, 6426-6438. doi: 10.1128/MCB.00359-08
25. Carey, B. W., Finley, L. W., Cross, J. R., Allis, C. D., and Thompson, C. B. (2015). Intracellular alpha-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518, 413-416. doi: 10.1038/nature13981
26. Cartwright, P., Mclean, C., Sheppard, A., Rivett, D., Jones, K., and Dalton, S. (2005). LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132, 885-896. doi: 10.1242/dev.01670
27. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., et al. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655. doi: 10.1016/S0092-8674(03)00392-1
28. Chambers, I., Silva, J., Colby, D., Nichols, J., Nijmeijer, B., Robertson, M., et al. (2007). Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234. doi: 10.1038/nature06403
29. Chang, T. C., Yu, D., Lee, Y. S., Wentzel, E. A., Arking, D. E., West, K. M., et al. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40, 43-50. doi: 10.1038/ng.2007.30
30. Chang, T. C., Zeitels, L. R., Hwang, H. W., Chivukula, R. R., Wentzel, E. A., Dews, M., et al. (2009). Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc. Natl. Acad. Sci. U.S.A. 106, 3384-3389. doi: 10.1073/pnas.0808300106
31. Chappell, J., and Dalton, S. (2013). Roles for MYC in the establishment and maintenance of pluripotency. Cold Spring Harb. Perspect. Med. 3:a014381. doi: 10.1101/cshperspect.a014381
32. Chappell, J., Sun, Y., Singh, A., and Dalton, S. (2013). MYC/MAX control ERK signaling and pluripotency by regulation of dual-specificity phosphatases 2 and 7. Genes Dev. 27, 725-733. doi: 10.1101/gad.211300.112
33. Charron, J., Malynn, B. A., Fisher, P., Stewart, V., Jeannotte, L., Goff, S. P., et al. (1992). Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 6, 2248-2257. doi: 10.1101/gad.6.12a.2248
34. Chen, J., Liu, H., Liu, J., Qi, J., Wei, B., Yang, J., et al. (2013). H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat. Genet. 45, 34-42. doi: 10.1038/ng.2491
35. Chen, X., Xu, H., Yuan, P., Fang, F., Huss, M., Vega, V. B., et al. (2008). Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117. doi: 10.1016/j.cell.2008.04.043
36. Cherry, A. B., and Daley, G. Q. (2012). Reprogramming cellular identity for regenerative medicine. Cell 148, 1110-1122. doi: 10.1016/j.cell.2012.02.031
37. Choi, Y. J., Lin, C. P., Ho, J. J., He, X., Okada, N., Bu, P., et al. (2011). miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat. Cell Biol. 13, 1353-1360. doi: 10.1038/ncb2366
38. Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., and Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45, 1127-1133. doi: 10.1038/ng.2762
39. Clevers, H., Loh, K. M., and Nusse, R. (2014). Stem cell signaling. An integral program for tissue renewal and regeneration: wnt signaling and stem cell control. Science 346:1248012. doi: 10.1126/science.1248012
40. Cockburn, K., and Rossant, J. (2010). Making the blastocyst: lessons from the mouse. J. Clin. Invest. 120, 995-1003. doi: 10.1172/JCI41229
41. Cohen, D. E., and Melton, D. (2011). Turning straw into gold: directing cell fate for regenerative medicine. Nat. Rev. Genet. 12, 243-252. doi: 10.1038/nrg2938
42. Cole, M. D., and Cowling, V. H. (2008). Transcription-independent functions of MYC: regulation of translation and DNA replication. Nat. Rev. Mol. Cell Biol. 9, 810-815. doi: 10.1038/nrm2467
43. Cole, M. D., and Nikiforov, M. A. (2006). Transcriptional activation by the Myc oncoprotein. Curr. Top. Microbiol. Immunol. 302, 33-50. doi: 10.1007/3-540-32952-8_2
44. Cole, M. F., Johnstone, S. E., Newman, J. J., Kagey, M. H., and Young, R. A. (2008). Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev. 22, 746-755. doi: 10.1101/gad.1642408
45. Cotterman, R., Jin, V. X., Krig, S. R., Lemen, J. M., Wey, A., Farnham, P. J., et al. (2008). N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor. Cancer Res. 68, 9654-9662. doi: 10.1158/0008-5472.CAN-08-1961
46. Dalton, S. (2015). Linking the cell cycle to cell fate decisions. Trends Cell Biol. 25, 592-600. doi: 10.1016/j.tcb.2015.07.007
47. Dang, C. V. (2012). MYC on the path to cancer. Cell 149, 22-35. doi: 10.1016/j.cell.2012.03.003
48. Dang, C. V. (2013). MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb. Perspect. Med. 3:a014217. doi: 10.1101/cshperspect.a014217
49. Das, P. P., Shao, Z., Beyaz, S., Apostolou, E., Pinello, L., De Los Angeles, A., et al. (2014). Distinct and combinatorial functions of Jmjd2b/Kdm4b and Jmjd2c/Kdm4c in mouse embryonic stem cell identity. Mol. Cell 53, 32-48. doi: 10.1016/j.molcel.2013.11.011
50. Davis, A. C., Wims, M., Spotts, G. D., Hann, S. R., and Bradley, A. (1993). A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7, 671-682. doi: 10.1101/gad.7.4.671
51. Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221. doi: 10.1126/science.1158799
52. Dinger, M. E., Amaral, P. P., Mercer, T. R., Pang, K. C., Bruce, S. J., Gardiner, B. B., et al. (2008). Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 18, 1433-1445. doi: 10.1101/gr.078378.108
53. Dubois, N. C., Adolphe, C., Ehninger, A., Wang, R. A., Robertson, E. J., and Trumpp, A. (2008). Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hematopoietic stem cell function. Development 135, 2455-2465. doi: 10.1242/dev.022707
54. D'urso, A., and Brickner, J. H. (2014). Mechanisms of epigenetic memory. Trends Genet. 30, 230-236. doi: 10.1016/j.tig.2014.04.004
55. Efroni, S., Duttagupta, R., Cheng, J., Dehghani, H., Hoeppner, D. J., Dash, C., et al. (2008). Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2, 437-447. doi: 10.1016/j.stem.2008.03.021
56. Eilers, M., and Eisenman, R. N. (2008). Myc's broad reach. Genes Dev. 22, 2755-2766. doi: 10.1101/gad.1712408
57. Evans, M. J., and Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156. doi: 10.1038/292154a0
58. Faast, R., White, J., Cartwright, P., Crocker, L., Sarcevic, B., and Dalton, S. (2004). Cdk6-cyclin D3 activity in murine ES cells is resistant to inhibition by p16(INK4a). Oncogene 23, 491-502. doi: 10.1038/sj.onc.1207133
59. Fabian, M. R., and Sonenberg, N. (2012). The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 19, 586-593. doi: 10.1038/nsmb.2296
60. Fagnocchi, L., Cherubini, A., Hatsuda, H., Fasciani, A., Mazzoleni, S., Poli, V., et al. (2016). A Myc-driven self-reinforcing regulatory network maintains mouse embryonic stem cell identity. Nat. Commun. 7:11903. doi: 10.1038/ncomms11903
61. Fagnocchi, L., Mazzoleni, S., and Zippo, A. (2016). Integration of signaling pathways with the epigenetic machinery in the maintenance of stem cells. Stem Cells Int. 2016:8652748. doi: 10.1155/2016/8652748
62. Farrell, A. S., and Sears, R. C. (2014). MYC degradation. Cold Spring Harb. Perspect. Med. 4:a014365. doi: 10.1101/cshperspect.a014365
63. Fazzio, T. G., Huff, J. T., and Panning, B. (2008). An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 134, 162-174. doi: 10.1016/j.cell.2008.05.031
64. Felsher, D. W., and Bishop, J. M. (1999). Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199-207. doi: 10.1016/S1097-2765(00)80367-6
65. Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., et al. (2003). Genomic targets of the human c-Myc protein. Genes Dev. 17, 1115-1129. doi: 10.1101/gad.1067003
66. Filipczyk, A. A., Laslett, A. L., Mummery, C., and Pera, M. F. (2007). Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Stem Cell Res. 1, 45-60. doi: 10.1016/j.scr.2007.09.002
67. Fluckiger, A. C., Marcy, G., Marchand, M., Negre, D., Cosset, F. L., Mitalipov, S., et al. (2006). Cell cycle features of primate embryonic stem cells. Stem Cells 24, 547-556. doi: 10.1634/stemcells.2005-0194
68. Frank, S. R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H. M., et al. (2003). MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 4, 575-580. doi: 10.1038/sj.embor.embor861
69. Frank, S. R., Schroeder, M., Fernandez, P., Taubert, S., and Amati, B. (2001). Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 15, 2069-2082. doi: 10.1101/gad.906601
70. Frye, M., Fisher, A. G., and Watt, F. M. (2007). Epidermal stem cells are defined by global histone modifications that are altered by Myc-induced differentiation. PLoS ONE 2:e763. doi: 10.1371/journal.pone.0000763
71. Fujikura, J., Yamato, E., Yonemura, S., Hosoda, K., Masui, S., Nakao, K., et al. (2002). Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev. 16, 784-789. doi: 10.1101/gad.968802
72. Gabay, M., Li, Y., and Felsher, D. W. (2014). MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb. Perspect. Med. 4:a014241. doi: 10.1101/cshperspect.a014241
73. Gafni, O., Weinberger, L., Mansour, A. A., Manor, Y. S., Chomsky, E., Ben-Yosef, D., et al. (2013). Derivation of novel human ground state naive pluripotent stem cells. Nature 504, 282-286. doi: 10.1038/nature12745
74. Garcia-Sanz, P., Quintanilla, A., Lafita, M. C., Moreno-Bueno, G., Garcia-Gutierrez, L., Tabor, V., et al. (2014). Sin3b interacts with Myc and decreases Myc levels. J. Biol. Chem. 289, 22221-22236. doi: 10.1074/jbc.M113.538744
75. Gaspar-Maia, A., Alajem, A., Meshorer, E., and Ramalho-Santos, M. (2011). Open chromatin in pluripotency and reprogramming. Nat. Rev. Mol. Cell Biol. 12, 36-47. doi: 10.1038/nrm3036
76. Gaspar-Maia, A., Qadeer, Z. A., Hasson, D., Ratnakumar, K., Leu, N. A., Leroy, G., et al. (2013). MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. Nat. Commun. 4, 1565. doi: 10.1038/ncomms2582
77. Goodrich, D. W., and Lee, W. H. (1992). Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53. Nature 360, 177-179. doi: 10.1038/360177a0
78. Greve, T. S., Judson, R. L., and Blelloch, R. (2013). microRNA control of mouse and human pluripotent stem cell behavior. Annu. Rev. Cell Dev. Biol. 29, 213-239. doi: 10.1146/annurev-cellbio-101512-122343
79. Grskovic, M., Javaherian, A., Strulovici, B., and Daley, G. Q. (2011). Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. Nat. Rev. Drug Discov. 10, 915-929. doi: 10.1038/nrd3577
80. Gu, W., Gaeta, X., Sahakyan, A., Chan, A. B., Hong, C. S., Kim, R., et al. (2016). Glycolytic metabolism plays a functional role in regulating human pluripotent stem cell state. Cell Stem Cell 19, 476-490. doi: 10.1016/j.stem.2016.08.008
81. Guccione, E., Martinato, F., Finocchiaro, G., Luzi, L., Tizzoni, L., Dall' Olio, V., et al. (2006). Myc-binding-site recognition in the human genome is determined by chromatin context. Nat. Cell Biol. 8, 764-770. doi: 10.1038/ncb1434
82. Guttman, M., Amit, I., Garber, M., French, C., Lin, M. F., Feldser, D., et al. (2009). Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227. doi: 10.1038/nature07672
83. Guttman, M., and Rinn, J. L. (2012). Modular regulatory principles of large non-coding RNAs. Nature 482, 339-346. doi: 10.1038/nature10887
84. Guttman, M., Donaghey, J., Carey, B. W., Garber, M., Grenier, J. K., Munson, G., et al. (2011). lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300. doi: 10.1038/nature10398
85. Guttman, M., Garber, M., Levin, J. Z., Donaghey, J., Robinson, J., Adiconis, X., et al. (2010). Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat. Biotechnol. 28, 503-510. doi: 10.1038/nbt.1633
86. Hann, S. R. (2014). MYC cofactors: molecular switches controlling diverse biological outcomes. Cold Spring Harb. Perspect. Med. 4:a014399. doi: 10.1101/cshperspect.a014399
87. Hatton, K. S., Mahon, K., Chin, L., Chiu, F. C., Lee, H. W., Peng, D., et al. (1996). Expression and activity of L-Myc in normal mouse development. Mol. Cell. Biol. 16, 1794-1804. doi: 10.1128/MCB.16.4.1794
88. Hayward, W. S., Neel, B. G., and Astrin, S. M. (1981). Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290, 475-480. doi: 10.1038/290475a0
89. Herkert, B., and Eilers, M. (2010). Transcriptional repression: the dark side of myc. Genes Cancer 1, 580-586. doi: 10.1177/1947601910379012
90. Ho, L., Miller, E. L., Ronan, J. L., Ho, W. Q., Jothi, R., and Crabtree, G. R. (2011). esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nat. Cell Biol. 13, 903-913. doi: 10.1038/ncb2285
91. Hu, G., and Wade, P. A. (2012). NuRD and pluripotency: a complex balancing act. Cell Stem Cell 10, 497-503. doi: 10.1016/j.stem.2012.04.011
92. Hu, G., Kim, J., Xu, Q., Leng, Y., Orkin, S. H., and Elledge, S. J. (2009). A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev. 23, 837-848. doi: 10.1101/gad.1769609
93. Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., et al. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26, 1269-1275. doi: 10.1038/nbt.1502
94. Jain, M., Arvanitis, C., Chu, K., Dewey, W., Leonhardt, E., Trinh, M., et al. (2002). Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297, 102-104. doi: 10.1126/science.1071489
95. Judson, R. L., Babiarz, J. E., Venere, M., and Blelloch, R. (2009). Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol. 27, 459-461. doi: 10.1038/nbt.1535
96. Kanellopoulou, C., Muljo, S. A., Kung, A. L., Ganesan, S., Drapkin, R., Jenuwein, T., et al. (2005). Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 19, 489-501. doi: 10.1101/gad.1248505
97. Karwacki-Neisius, V., Goke, J., Osorno, R., Halbritter, F., Ng, J. H., Weisse, A. Y., et al. (2013). Reduced Oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by Oct4 and Nanog. Cell Stem Cell 12, 531-545. doi: 10.1016/j.stem.2013.04.023
98. Keller, G. (2005). Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19, 1129-1155. doi: 10.1101/gad.1303605
99. Kidder, B. L., Yang, J., and Palmer, S. (2008). Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS ONE 3:e3932. doi: 10.1371/journal.pone.0003932
100. Kim, J., and Zaret, K. S. (2015). Reprogramming of human cancer cells to pluripotency for models of cancer progression. EMBO J. 34, 739-747. doi: 10.15252/embj.201490736
101. Kim, J., Chu, J., Shen, X., Wang, J., and Orkin, S. H. (2008). An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132, 1049-1061. doi: 10.1016/j.cell.2008.02.039
102. Kim, J., Woo, A. J., Chu, J., Snow, J. W., Fujiwara, Y., Kim, C. G., et al. (2010). A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143, 313-324. doi: 10.1016/j.cell.2010.09.010
103. Knoepfler, P. S., Zhang, X. Y., Cheng, P. F., Gafken, P. R., Mcmahon, S. B., and Eisenman, R. N. (2006). Myc influences global chromatin structure. EMBO J. 25, 2723-2734. doi: 10.1038/sj.emboj.7601152
104. Krepelova, A., Neri, F., Maldotti, M., Rapelli, S., and Oliviero, S. (2014). Myc and max genome-wide binding sites analysis links the Myc regulatory network with the polycomb and the core pluripotency networks in mouse embryonic stem cells. PLoS ONE 9:e88933. doi: 10.1371/journal.pone.0088933
105. Kress, T. R., Sabo, A., and Amati, B. (2015). MYC: connecting selective transcriptional control to global RNA production. Nat. Rev. Cancer 15, 593-607. doi: 10.1038/nrc3984
106. Land, H., Parada, L. F., and Weinberg, R. A. (1983). Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602. doi: 10.1038/304596a0
107. Laplane, L., Beke, A., Vainchenker, W., and Solary, E. (2015). Concise review: induced pluripotent stem cells as new model systems in oncology. Stem Cells 33, 2887-2892. doi: 10.1002/stem.2099
108. Laurenti, E., Varnum-Finney, B., Wilson, A., Ferrero, I., Blanco-Bose, W. E., Ehninger, A., et al. (2008). Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell 3, 611-624. doi: 10.1016/j.stem.2008.09.005
109. Lee, S. H., Chen, T. Y., Dhar, S. S., Gu, B., Chen, K., Kim, Y. Z., et al. (2016). A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness. Nucleic Acids Res. 44, 10603-10618. doi: 10.1093/nar/gkw788
110. Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R. M., et al. (2006). Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125, 301-313. doi: 10.1016/j.cell.2006.02.043
111. Leese, H. J. (2012). Metabolism of the preimplantation embryo: 40 years on. Reproduction 143, 417-427. doi: 10.1530/REP-11-0484
112. Levens, D. (2010). You don't muck with MYC. Genes Cancer 1, 547-554. doi: 10.1177/1947601910377492
113. Liang, J., Wan, M., Zhang, Y., Gu, P., Xin, H., Jung, S. Y., et al. (2008). Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 10, 731-739. doi: 10.1038/ncb1736
114. Lin, C. H., Jackson, A. L., Guo, J., Linsley, P. S., and Eisenman, R. N. (2009). Myc-regulated microRNAs attenuate embryonic stem cell differentiation. EMBO J. 28, 3157-3170. doi: 10.1038/emboj.2009.254
115. Lin, C. H., Lin, C., Tanaka, H., Fero, M. L., and Eisenman, R. N. (2009). Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc. PLoS ONE 4:e7839. doi: 10.1371/journal.pone.0007839
116. Lin, C. Y., Loven, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., et al. (2012). Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56-67. doi: 10.1016/j.cell.2012.08.026
117. Loewer, S., Cabili, M. N., Guttman, M., Loh, Y. H., Thomas, K., Park, I. H., et al. (2010). Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat. Genet. 42, 1113-1117. doi: 10.1038/ng.710
118. Loh, Y. H., Wu, Q., Chew, J. L., Vega, V. B., Zhang, W., Chen, X., et al. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38, 431-440. doi: 10.1038/ng1760
119. Lunt, S. Y., and Vander Heiden, M. G. (2011). Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27, 441-464. doi: 10.1146/annurev-cellbio-092910-154237
120. Mac Auley, A., Werb, Z., and Mirkes, P. E. (1993). Characterization of the unusually rapid cell cycles during rat gastrulation. Development 117, 873-883
121. Malynn, B. A., De Alboran, I. M., O'hagan, R. C., Bronson, R., Davidson, L., Depinho, R. A., et al. (2000). N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 14, 1390-1399. doi: 10.1101/gad.14.11.1390
122. Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H., et al. (2012). The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149, 590-604. doi: 10.1016/j.cell.2012.03.026
123. Marson, A., Levine, S. S., Cole, M. F., Frampton, G. M., Brambrink, T., Johnstone, S., et al. (2008). Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134, 521-533. doi: 10.1016/j.cell.2008.07.020
124. Martin, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U.S.A. 78, 7634-7638. doi: 10.1073/pnas.78.12.7634
125. Masui, S., Nakatake, Y., Toyooka, Y., Shimosato, D., Yagi, R., Takahashi, K., et al. (2007). Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9, 625-635. doi: 10.1038/ncb1589
126. Mcdonel, P., Demmers, J., Tan, D. W., Watt, F., and Hendrich, B. D. (2012). Sin3a is essential for the genome integrity and viability of pluripotent cells. Dev. Biol. 363, 62-73. doi: 10.1016/j.ydbio.2011.12.019
127. Mcmahon, S. B., Wood, M. A., and Cole, M. D. (2000). The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol. Cell. Biol. 20, 556-562. doi: 10.1128/MCB.20.2.556-562.2000
128. Melton, C., Judson, R. L., and Blelloch, R. (2010). Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463, 621-626. doi: 10.1038/nature08725
129. Meshorer, E., and Misteli, T. (2006). Chromatin in pluripotent embryonic stem cells and differentiation. Nat. Rev. Mol. Cell Biol. 7, 540-546. doi: 10.1038/nrm1938
130. Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., et al. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55. doi: 10.1038/nature07056
131. Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., et al. (2007). Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560. doi: 10.1038/nature06008
132. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., et al. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642. doi: 10.1016/S0092-8674(03)00393-3
133. Moazed, D. (2011). Mechanisms for the inheritance of chromatin states. Cell 146, 510-518. doi: 10.1016/j.cell.2011.07.013
134. Moussaieff, A., Kogan, N. M., and Aberdam, D. (2015). Concise review: energy metabolites: key mediators of the epigenetic state of pluripotency. Stem Cells 33, 2374-2380. doi: 10.1002/stem.2041
135. Moussaieff, A., Rouleau, M., Kitsberg, D., Cohen, M., Levy, G., Barasch, D., et al. (2015). Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 21, 392-402. doi: 10.1016/j.cmet.2015.02.002
136. Murchison, E. P., Partridge, J. F., Tam, O. H., Cheloufi, S., and Hannon, G. J. (2005). Characterization of Dicer-deficient murine embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 102, 12135-12140. doi: 10.1073/pnas.0505479102
137. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106. doi: 10.1038/nbt1374
138. Nakagawa, M., Takizawa, N., Narita, M., Ichisaka, T., and Yamanaka, S. (2010). Promotion of direct reprogramming by transformation-deficient Myc. Proc. Natl. Acad. Sci. U.S.A. 107, 14152-14157. doi: 10.1073/pnas.1009374107
139. Nashun, B., Hill, P. W., and Hajkova, P. (2015). Reprogramming of cell fate: epigenetic memory and the erasure of memories past. EMBO J. 34, 1296-1308. doi: 10.15252/embj.201490649
140. Neganova, I., Tilgner, K., Buskin, A., Paraskevopoulou, I., Atkinson, S. P., Peberdy, D., et al. (2014). CDK1 plays an important role in the maintenance of pluripotency and genomic stability in human pluripotent stem cells. Cell Death Dis. 5, e1508. doi: 10.1038/cddis.2014.464
141. Neganova, I., Vilella, F., Atkinson, S. P., Lloret, M., Passos, J. F., Von Zglinicki, T., et al. (2011). An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells 29, 651-659. doi: 10.1002/stem.620
142. Neganova, I., Zhang, X., Atkinson, S., and Lako, M. (2009). Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene 28, 20-30. doi: 10.1038/onc.2008.358
143. Neri, F., Zippo, A., Krepelova, A., Cherubini, A., Rocchigiani, M., and Oliviero, S. (2012). Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells. Mol. Cell. Biol. 32, 840-851. doi: 10.1128/MCB.06148-11
144. Ng, H. H., and Surani, M. A. (2011). The transcriptional and signalling networks of pluripotency. Nat. Cell Biol. 13, 490-496. doi: 10.1038/ncb0511-490
145. Ng, S. Y., Johnson, R., and Stanton, L. W. (2012). Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J. 31, 522-533. doi: 10.1038/emboj.2011.459
146. Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., et al. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391. doi: 10.1016/S0092-8674(00)81769-9
147. Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., et al. (2012). c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151, 68-79. doi: 10.1016/j.cell.2012.08.033
148. Niwa, H. (2010). Mouse ES cell culture system as a model of development. Dev. Growth Differ. 52, 275-283. doi: 10.1111/j.1440-169X.2009.01166.x
149. Niwa, H., Burdon, T., Chambers, I., and Smith, A. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048-2060. doi: 10.1101/gad.12.13.2048
150. Okita, K., Ichisaka, T., and Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317. doi: 10.1038/nature05934
151. Pan, G., Tian, S., Nie, J., Yang, C., Ruotti, V., Wei, H., et al. (2007). Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1, 299-312. doi: 10.1016/j.stem.2007.08.003
152. Park, I. H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., et al. (2008). Disease-specific induced pluripotent stem cells. Cell 134, 877-886. doi: 10.1016/j.cell.2008.07.041
153. Pasque, V., Radzisheuskaya, A., Gillich, A., Halley-Stott, R. P., Panamarova, M., Zernicka-Goetz, M., et al. (2012). Histone variant macroH2A marks embryonic differentiation in vivo and acts as an epigenetic barrier to induced pluripotency. J. Cell Sci. 125, 6094-6104. doi: 10.1242/jcs.113019
154. Pauklin, S., and Vallier, L. (2013). The cell-cycle state of stem cells determines cell fate propensity. Cell 155, 135-147. doi: 10.1016/j.cell.2013.08.031
155. Pelengaris, S., Khan, M., and Evan, G. I. (2002). Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109, 321-334. doi: 10.1016/S0092-8674(02)00738-9
156. Power, M. A., and Tam, P. P. (1993). Onset of gastrulation, morphogenesis and somitogenesis in mouse embryos displaying compensatory growth. Anat. Embryol. 187, 493-504. doi: 10.1007/BF00174425
157. Psathas, J. N., and Thomas-Tikhonenko, A. (2014). MYC and the art of microRNA maintenance. Cold Spring Harb. Perspect. Med. 4:a014175. doi: 10.1101/cshperspect.a014175
158. Ringrose, L., and Paro, R. (2004). Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu. Rev. Genet. 38, 413-443. doi: 10.1146/annurev.genet.38.072902.091907
159. Robinton, D. A., and Daley, G. Q. (2012). The promise of induced pluripotent stem cells in research and therapy. Nature 481, 295-305. doi: 10.1038/nature10761
160. Rosa, A., and Ballarino, M. (2016). Long noncoding RNA regulation of pluripotency. Stem Cells Int. 2016:1797692. doi: 10.1155/2016/1797692
161. Rosa, A., and Brivanlou, A. H. (2013). Regulatory non-coding RNAs in pluripotent stem cells. Int. J. Mol. Sci. 14, 14346-14373. doi: 10.3390/ijms140714346
162. Rustgi, A. K., Dyson, N., and Bernards, R. (1991). Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352, 541-544. doi: 10.1038/352541a0
163. Ryall, J. G., Cliff, T., Dalton, S., and Sartorelli, V. (2015). Metabolic reprogramming of stem cell epigenetics. Cell Stem Cell 17, 651-662. doi: 10.1016/j.stem.2015.11.012
164. Sabo, A., Kress, T. R., Pelizzola, M., De Pretis, S., Gorski, M. M., Tesi, A., et al. (2014). Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature 511, 488-492. doi: 10.1038/nature13537
165. Savatier, P., Huang, S., Szekely, L., Wiman, K. G., and Samarut, J. (1994). Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 9, 809-818
166. Sawai, S., Shimono, A., Wakamatsu, Y., Palmes, C., Hanaoka, K., and Kondoh, H. (1993). Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 117, 1445-1455
167. Scognamiglio, R., Cabezas-Wallscheid, N., Thier, M. C., Altamura, S., Reyes, A., Prendergast, A. M., et al. (2016). Myc depletion induces a pluripotent dormant state mimicking diapause. Cell 164, 668-680. doi: 10.1016/j.cell.2015.12.033
168. Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., and Nevins, J. R. (2000). Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14, 2501-2514. doi: 10.1101/gad.836800
169. Sela, Y., Molotski, N., Golan, S., Itskovitz-Eldor, J., and Soen, Y. (2012). Human embryonic stem cells exhibit increased propensity to differentiate during the G1 phase prior to phosphorylation of retinoblastoma protein. Stem Cells 30, 1097-1108. doi: 10.1002/stem.1078
170. Seoane, J., Pouponnot, C., Staller, P., Schader, M., Eilers, M., and Massague, J. (2001). TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 3, 400-408. doi: 10.1038/35070086
171. Shachaf, C. M., Kopelman, A. M., Arvanitis, C., Karlsson, A., Beer, S., Mandl, S., et al. (2004). MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431, 1112-1117. doi: 10.1038/nature03043
172. Sheik Mohamed, J., Gaughwin, P. M., Lim, B., Robson, P., and Lipovich, L. (2010). Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. RNA 16, 324-337. doi: 10.1261/rna.1441510
173. Shipony, Z., Mukamel, Z., Cohen, N. M., Landan, G., Chomsky, E., Zeliger, S. R., et al. (2014). Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. Nature 513, 115-119. doi: 10.1038/nature13458
174. Shiraki, N., Shiraki, Y., Tsuyama, T., Obata, F., Miura, M., Nagae, G., et al. (2014). Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. Cell Metab. 19, 780-794. doi: 10.1016/j.cmet.2014.03.017
175. Shyh-Chang, N., and Daley, G. Q. (2013). Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell 12, 395-406. doi: 10.1016/j.stem.2013.03.005
176. Shyh-Chang, N., Locasale, J. W., Lyssiotis, C. A., Zheng, Y., Teo, R. Y., Ratanasirintrawoot, S., et al. (2013). Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 339, 222-226. doi: 10.1126/science.1226603
177. Silva, J., Nichols, J., Theunissen, T. W., Guo, G., Van Oosten, A. L., Barrandon, O., et al. (2009). Nanog is the gateway to the pluripotent ground state. Cell 138, 722-737. doi: 10.1016/j.cell.2009.07.039
178. Singh, A. M., and Dalton, S. (2009). The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 5, 141-149. doi: 10.1016/j.stem.2009.07.003
179. Smith, A. G., Heath, J. K., Donaldson, D. D., Wong, G. G., Moreau, J., Stahl, M., et al. (1988). Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688-690. doi: 10.1038/336688a0
180. Smith, K. N., Lim, J. M., Wells, L., and Dalton, S. (2011). Myc orchestrates a regulatory network required for the establishment and maintenance of pluripotency. Cell Cycle 10, 592-597. doi: 10.4161/cc.10.4.14792
181. Smith, K. N., Singh, A. M., and Dalton, S. (2010). Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 7, 343-354. doi: 10.1016/j.stem.2010.06.023
182. Smith, K., and Dalton, S. (2010). Myc transcription factors: key regulators behind establishment and maintenance of pluripotency. Regen. Med. 5, 947-959. doi: 10.2217/rme.10.79
183. Snow, M. H. L. (1977). Gastrulation in the mouse: growth and regionalization of the epiblast. Development 42, 293-303
184. Sodir, N. M., Swigart, L. B., Karnezis, A. N., Hanahan, D., Evan, G. I., and Soucek, L. (2011). Endogenous Myc maintains the tumor microenvironment. Genes Dev. 25, 907-916. doi: 10.1101/gad.2038411
185. Solomon, D. L., Amati, B., and Land, H. (1993). Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Nucleic Acids Res. 21, 5372-5376. doi: 10.1093/nar/21.23.5372
186. Soucek, L., Whitfield, J., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., et al. (2008). Modelling Myc inhibition as a cancer therapy. Nature 455, 679-683. doi: 10.1038/nature07260
187. Soufi, A., Donahue, G., and Zaret, K. S. (2012). Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151, 994-1004. doi: 10.1016/j.cell.2012.09.045
188. Sridharan, R., Gonzales-Cope, M., Chronis, C., Bonora, G., Mckee, R., Huang, C., et al. (2013). Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1gamma in reprogramming to pluripotency. Nat. Cell Biol. 15, 872-882. doi: 10.1038/ncb2768
189. Sridharan, R., Tchieu, J., Mason, M. J., Yachechko, R., Kuoy, E., Horvath, S., et al. (2009). Role of the murine reprogramming factors in the induction of pluripotency. Cell 136, 364-377. doi: 10.1016/j.cell.2009.01.001
190. Staller, P., Peukert, K., Kiermaier, A., Seoane, J., Lukas, J., Karsunky, H., et al. (2001). Repression of p15INK4b expression by Myc through association with Miz-1. Nat. Cell Biol. 3, 392-399. doi: 10.1038/35070076
191. Stanton, B. R., Perkins, A. S., Tessarollo, L., Sassoon, D. A., and Parada, L. F. (1992). Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev. 6, 2235-2247. doi: 10.1101/gad.6.12a.2235
192. Stead, E., White, J., Faast, R., Conn, S., Goldstone, S., Rathjen, J., et al. (2002). Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21, 8320-8333. doi: 10.1038/sj.onc.1206015
193. Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., and Dang, C. V. (2015). MYC, metabolism, and cancer. Cancer Discov. 5, 1024-1039. doi: 10.1158/2159-8290.CD-15-0507
194. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. doi: 10.1016/j.cell.2006.07.024
195. Takahashi, K., and Yamanaka, S. (2016). A decade of transcription factor-mediated reprogramming to pluripotency. Nat. Rev. Mol. Cell Biol. 17, 183-193. doi: 10.1038/nrm.2016.8
196. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. doi: 10.1016/j.cell.2007.11.019
197. Tee, W. W., and Reinberg, D. (2014). Chromatin features and the epigenetic regulation of pluripotency states in ESCs. Development 141, 2376-2390. doi: 10.1242/dev.096982
198. Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J., Evans, E. P., Mack, D. L., et al. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199. doi: 10.1038/nature05972
199. Theunissen, T. W., and Jaenisch, R. (2014). Molecular control of induced pluripotency. Cell Stem Cell 14, 720-734. doi: 10.1016/j.stem.2014.05.002
200. Theunissen, T. W., Powell, B. E., Wang, H., Mitalipova, M., Faddah, D. A., Reddy, J., et al. (2014). Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell 15, 471-487. doi: 10.1016/j.stem.2014.07.002
201. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147. doi: 10.1126/science.282.5391.1145
202. Toyooka, Y., Shimosato, D., Murakami, K., Takahashi, K., and Niwa, H. (2008). Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 135, 909-918. doi: 10.1242/dev.017400
203. Trounson, A., and Dewitt, N. D. (2016). Pluripotent stem cells progressing to the clinic. Nat. Rev. Mol. Cell Biol. 17, 194-200. doi: 10.1038/nrm.2016.10
204. Trumpp, A., Refaeli, Y., Oskarsson, T., Gasser, S., Murphy, M., Martin, G. R., et al. (2001). c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414, 768-773. doi: 10.1038/414768a
205. Tu, W. B., Helander, S., Pilstal, R., Hickman, K. A., Lourenco, C., Jurisica, I., et al. (2015). Myc and its interactors take shape. Biochim. Biophys. Acta 1849, 469-483. doi: 10.1016/j.bbagrm.2014.06.002
206. Van Blerkom, J. (2009). Mitochondria in early mammalian development. Semin. Cell Dev. Biol. 20, 354-364. doi: 10.1016/j.semcdb.2008.12.005
207. Van Riggelen, J., Yetil, A., and Felsher, D. W. (2010). MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. Cancer 10, 301-309. doi: 10.1038/nrc2819
208. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033. doi: 10.1126/science.1160809
209. Varlakhanova, N. V., Cotterman, R. F., Devries, W. N., Morgan, J., Donahue, L. R., Murray, S., et al. (2010). myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation 80, 9-19. doi: 10.1016/j.diff.2010.05.001
210. Varlakhanova, N., Cotterman, R., Bradnam, K., Korf, I., and Knoepfler, P. S. (2011). Myc and Miz-1 have coordinate genomic functions including targeting Hox genes in human embryonic stem cells. Epigenetics Chromatin 4:20. doi: 10.1186/1756-8935-4-20
211. Vennstrom, B., Sheiness, D., Zabielski, J., and Bishop, J. M. (1982). Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J. Virol. 42, 773-779
212. Walz, S., Lorenzin, F., Morton, J., Wiese, K. E., Von Eyss, B., Herold, S., et al. (2014). Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature 511, 483-487. doi: 10.1038/nature13473
213. Wang, F., and Higgins, J. M. (2013). Histone modifications and mitosis: countermarks, landmarks, and bookmarks. Trends Cell Biol. 23, 175-184. doi: 10.1016/j.tcb.2012.11.005
214. Wang, J., Alexander, P., Wu, L., Hammer, R., Cleaver, O., and Mcknight, S. L. (2009). Dependence of mouse embryonic stem cells on threonine catabolism. Science 325, 435-439. doi: 10.1126/science.1173288
215. Wang, J., Hevi, S., Kurash, J. K., Lei, H., Gay, F., Bajko, J., et al. (2009). The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat. Genet. 41, 125-129. doi: 10.1038/ng.268
216. Wang, Y., Baskerville, S., Shenoy, A., Babiarz, J. E., Baehner, L., and Blelloch, R. (2008). Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat. Genet. 40, 1478-1483. doi: 10.1038/ng.250
217. Wang, Y., Medvid, R., Melton, C., Jaenisch, R., and Blelloch, R. (2007). DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet. 39, 380-385. doi: 10.1038/ng1969
218. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314. doi: 10.1126/science.123.3191.309
219. Ware, C. B., Nelson, A. M., Mecham, B., Hesson, J., Zhou, W., Jonlin, E. C., et al. (2014). Derivation of naive human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 111, 4484-4489. doi: 10.1073/pnas.1319738111
220. Weinberger, L., Ayyash, M., Novershtern, N., and Hanna, J. H. (2016). Dynamic stem cell states: naive to primed pluripotency in rodents and humans. Nat. Rev. Mol. Cell Biol. 17, 155-169. doi: 10.1038/nrm.2015.28
221. Wernig, M., Meissner, A., Cassady, J. P., and Jaenisch, R. (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10-12. doi: 10.1016/j.stem.2007.12.001
222. White, J., Stead, E., Faast, R., Conn, S., Cartwright, P., and Dalton, S. (2005). Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol. Biol. Cell 16, 2018-2027. doi: 10.1091/mbc.E04-12-1056
223. Williams, R. L., Hilton, D. J., Pease, S., Willson, T. A., Stewart, C. L., Gearing, D. P., et al. (1988). Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-687. doi: 10.1038/336684a0
224. Wu, S. M., and Hochedlinger, K. (2011). Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol. 13, 497-505. doi: 10.1038/ncb0511-497
225. Ying, Q. L., Nichols, J., Chambers, I., and Smith, A. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292. doi: 10.1016/S0092-8674(03)00847-X
226. Ying, Q. L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., et al. (2008). The ground state of embryonic stem cell self-renewal. Nature 453, 519-523. doi: 10.1038/nature06968
227. Young, R. A. (2011). Control of the embryonic stem cell state. Cell 144, 940-954. doi: 10.1016/j.cell.2011.01.032
228. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920. doi: 10.1126/science.1151526
229. Zeller, K. I., Zhao, X., Lee, C. W., Chiu, K. P., Yao, F., Yustein, J. T., et al. (2006). Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. U.S.A. 103, 17834-17839. doi: 10.1073/pnas.0604129103
230. Zeltner, N., and Studer, L. (2015). Pluripotent stem cell-based disease modeling: current hurdles and future promise. Curr. Opin. Cell Biol. 37, 102-110. doi: 10.1016/j.ceb.2015.10.008
231. Zhang, J., Khvorostov, I., Hong, J. S., Oktay, Y., Vergnes, L., Nuebel, E., et al. (2011). UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J. 30, 4860-4873. doi: 10.1038/emboj.2011.401
232. Zhang, J., Nuebel, E., Daley, G. Q., Koehler, C. M., and Teitell, M. A. (2012). Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell 11, 589-595. doi: 10.1016/j.stem.2012.10.005
233. Zhao, X. D., Han, X., Chew, J. L., Liu, J., Chiu, K. P., Choo, A., et al. (2007). Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 1, 286-298. doi: 10.1016/j.stem.2007.08.004
234. Zheng, G. X., Do, B. T., Webster, D. E., Khavari, P. A., and Chang, H. Y. (2014). Dicer-microRNA-Myc circuit promotes transcription of hundreds of long noncoding RNAs. Nat. Struct. Mol. Biol. 21, 585-590. doi: 10.1038/nsmb.2842
235. Zhong, X., Li, N., Liang, S., Huang, Q., Coukos, G., and Zhang, L. (2010). Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells. J. Biol. Chem. 285, 41961-41971. doi: 10.1074/jbc.M110.169607
236. Zhu, H., Lensch, M. W., Cahan, P., and Daley, G. Q. (2011). Investigating monogenic and complex diseases with pluripotent stem cells. Nat. Rev. Genet. 12, 266-275. doi: 10.1038/nrg2951
237. Zhu, J., Adli, M., Zou, J. Y., Verstappen, G., Coyne, M., Zhang, X., et al. (2013). Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 152, 642-654. doi: 10.1016/j.cell.2012.12.033
238. Zimmerman, K. A., Yancopoulos, G. D., Collum, R. G., Smith, R. K., Kohl, N. E., Denis, K. A., et al. (1986). Differential expression of myc family genes during murine development. Nature 319, 780-783. doi: 10.1038/319780a0
239. Zippo, A., De Robertis, A., Serafini, R., and Oliviero, S. (2007). PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat. Cell Biol. 9, 932-944. doi: 10.1038/ncb1618
240. Zippo, A., Serafini, R., Rocchigiani, M., Pennacchini, S., Krepelova, A., and Oliviero, S. (2009). Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 138, 1122-1136. doi: 10.1016/j.cell.2009.07.031